Vontobel Holding Ltd. Decreases Stock Position in Encompass Health Co. (NYSE:EHC)

Vontobel Holding Ltd. reduced its position in Encompass Health Co. (NYSE:EHC) by 51.8% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 13,610 shares of the company’s stock after selling 14,609 shares during the period. Vontobel Holding Ltd.’s holdings in Encompass Health were worth $908,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of the company. Lazard Asset Management LLC boosted its holdings in shares of Encompass Health by 14.3% in the fourth quarter. Lazard Asset Management LLC now owns 1,290 shares of the company’s stock worth $77,000 after acquiring an additional 161 shares during the period. Bank of Montreal Can boosted its holdings in shares of Encompass Health by 1.5% in the first quarter. Bank of Montreal Can now owns 11,340 shares of the company’s stock worth $806,000 after acquiring an additional 173 shares during the period. Creative Planning boosted its holdings in shares of Encompass Health by 3.5% in the second quarter. Creative Planning now owns 6,074 shares of the company’s stock worth $340,000 after acquiring an additional 204 shares during the period. First Horizon Advisors Inc. boosted its holdings in shares of Encompass Health by 18.8% in the first quarter. First Horizon Advisors Inc. now owns 1,415 shares of the company’s stock worth $77,000 after acquiring an additional 224 shares during the period. Finally, Treasurer of the State of North Carolina boosted its holdings in shares of Encompass Health by 0.5% in the third quarter. Treasurer of the State of North Carolina now owns 48,339 shares of the company’s stock worth $3,246,000 after acquiring an additional 231 shares during the period. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Trading Up 0.8 %

Shares of EHC stock opened at $79.22 on Monday. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.19. The business has a 50-day moving average price of $77.38 and a two-hundred day moving average price of $70.36. Encompass Health Co. has a 12-month low of $57.55 and a 12-month high of $83.73. The firm has a market cap of $7.93 billion, a P/E ratio of 22.83, a price-to-earnings-growth ratio of 1.47 and a beta of 0.94.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Wednesday, February 7th. The company reported $0.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $0.12. Encompass Health had a return on equity of 17.69% and a net margin of 7.33%. The firm had revenue of $1.25 billion during the quarter, compared to analyst estimates of $1.24 billion. Equities analysts anticipate that Encompass Health Co. will post 3.96 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 0.76%. The ex-dividend date was Thursday, March 28th. Encompass Health’s dividend payout ratio (DPR) is currently 17.29%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on EHC shares. Stephens reaffirmed an “overweight” rating and issued a $85.00 price target on shares of Encompass Health in a report on Tuesday, January 16th. Barclays raised their price target on Encompass Health from $95.00 to $101.00 and gave the stock an “overweight” rating in a report on Thursday, March 28th. Truist Financial raised their price target on Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a report on Friday, February 9th. Mizuho lifted their price objective on Encompass Health from $77.00 to $82.00 and gave the company a “buy” rating in a research note on Friday, February 9th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $83.00 price objective on shares of Encompass Health in a research note on Friday, February 9th. Eight equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Encompass Health has a consensus rating of “Buy” and a consensus target price of $83.22.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.